טרג'נטה דואו 2.5 מג850  מג Israël - Hebreeuws - Ministry of Health

טרג'נטה דואו 2.5 מג850 מג

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; linagliptin 2.5 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

טרג'נטה דואו 2.5 מג1000 מג Israël - Hebreeuws - Ministry of Health

טרג'נטה דואו 2.5 מג1000 מג

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - linagliptin 2.5 mg; metformin hydrochloride 1000 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

מונוקורד 40 Israël - Hebreeuws - Ministry of Health

מונוקורד 40

dexcel ltd, israel - isosorbide mononitrate - טבליה - isosorbide mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks, treatment of congestive heart failure.

מונוקורד 20 Israël - Hebreeuws - Ministry of Health

מונוקורד 20

dexcel ltd, israel - isosorbide mononitrate - טבליה - isosorbide mononitrate 20 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks. treatment of congestive heart failure.

סילאזפריל טבע  2.5 מג Israël - Hebreeuws - Ministry of Health

סילאזפריל טבע 2.5 מג

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

סילאזפריל טבע  2.5 מג Israël - Hebreeuws - Ministry of Health

סילאזפריל טבע 2.5 מג

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

סילאזפריל טבע  5 מג Israël - Hebreeuws - Ministry of Health

סילאזפריל טבע 5 מג

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

סילאזפריל טבע  5 מג Israël - Hebreeuws - Ministry of Health

סילאזפריל טבע 5 מג

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

סילאזפריל פלוס טבע  Israël - Hebreeuws - Ministry of Health

סילאזפריל פלוס טבע

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

ואלסרטן דקסל 40 Israël - Hebreeuws - Ministry of Health

ואלסרטן דקסל 40

dexcel pharma technologies ltd - valsartan - טבליות מצופות פילם - valsartan 40 mg - valsartan - valsartan - valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalisations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.